Abstract
Nowadays, effective cancer treatment is still one of the most challenging missions in the scientific community. A primary limitation to most conventional anticancer drugs is their adverse uptake by normal tissues, fast metabolism and lack of tumour cell targeting property. One way to overcome these disadvantages is the application of nanoparticles as the carriers of widely known therapeutic substances. In this work, we devoted our efforts to prepare pH-sensitive magnetic nanoparticles as drug carriers for sustained and controlled release of methotrexate (MTX) via self-assembly of MgAl-LDH and Fe 3 O 4 nanoparticles, which is an economic and environmentally friendly process, and also investigated the physical and chemical properties as well as the drug release performance. We further found that the carriers had a suitable size, good stability and magnetic responsibility; the MTX successfully loaded onto the carriers at a drug loading efficiency of 89.16%. In addition, the in vitro drug release studies showed that the MTX-carriers had excellent pH-sensitivity, 86.21% of MTX was released within 48 h at pH 3.5. Moreover, the MTT assays in cancer cells (HepG2) demonstrated that MTX-carriers exhibited high anticancer activity while the carriers were practically non-toxic.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.